Ursula Seelhorst

Suggest Changes
Learn More
  • Andreas Meinitzer, Ursula Seelhorst, +4 authors Winfried März
  • Clinical chemistry
  • 2007
BACKGROUND Asymmetrical dimethylarginine (ADMA) is increased in conditions associated with increased risk of atherosclerosis. We investigated the use of ADMA to predict total and cardiovascular(More)
BACKGROUND Lipoprotein-associated phospholipase A(2) (LpPLA(2)), also denoted as platelet-activating factor acetylhydrolase, is a lipoprotein-bound enzyme involved in inflammation and(More)